Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 1/20 | 0.33 |
| ▸ | CD81 | P60033 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
| ▸ | EP300 | Q09472 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17911297 | 0.93 | TBXAS1 (0.35) | TBXAS1CD81PPARGEP300 | |
| SCHEMBL3768512 | 0.92 | TBXAS1 (0.32) | TBXAS1CD81 | |
| SCHEMBL400292 | 0.86 | TBXAS1 (0.33) | TBXAS1CD81PPARGEP300 | |
| SCHEMBL809437 | 0.86 | TBXAS1 (0.33) | TBXAS1CD81PPARGEP300 | |
| SCHEMBL1581278 | 0.86 | TBXAS1 (0.33) | TBXAS1CD81PPARGEP300 | |
| SCHEMBL30912180 | 0.85 | TSHR (0.39) | — | |
| SCHEMBL25347894 | 0.84 | TBXAS1 (0.34) | TBXAS1CD81PPARGEP300 | |
| SCHEMBL20958100 | 0.83 | EP300 (0.37) | TBXAS1EP300 | |
| SCHEMBL20958102 | 0.83 | EP300 (0.37) | TBXAS1EP300 | |
| SCHEMBL8466019 | 0.82 | TBXAS1 (0.32) | TBXAS1CD81 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3756874-A2 | PINHOLE CONTACT LENS FORMING JIG | Seed Co., Ltd. (JP) | 2020-12-30 | — | — | EP | disclosed |
| US-9238715-B2 | Polymerizable composition for ophthalmic and medical use and antimicrobial composition obtained by polymerizing the polymerizable composition | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2016-01-19 | — | — | US | disclosed |
| EP-2650021-B1 | MEDICAL DEVICE FOR CONTROLLED RELEASE OF DRUG | SEED CO LTD (JP) | 2015-12-09 | — | — | EP | disclosed |
| US-9056880-B2 | Process for producing hydrolysis-resistant silicone compounds | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2015-06-16 | — | — | US | disclosed |
| US-9034942-B2 | Polymer material, ophthalmic lens and contact lens | MENICON CO., LTD. (JP) | 2015-05-19 | — | — | US | disclosed |
| US-8921449-B2 | Hydrolysis-resistant silicone compounds | JOHNSON & JOHNSON VISION CARE INC. (US) | 2014-12-30 | — | — | US | disclosed |
| US-20140163133-A1 | POLYMERIZABLE COMPOSITION FOR OPHTHALMIC AND MEDICAL USE AND ANTIMICROBIAL COMPOSITION OBTAINED BY POLYMERIZING THE POLYMERIZABLE COMPOSITION | MENICON CO., LTD (JP) | 2014-06-12 | — | — | US | disclosed |
| US-20140128564-A1 | PROCESS FOR PRODUCING HYDROLYSIS-RESISTANT SILICONE COMPOUNDS | FUJISAWA KAZUHIKO (JP) | 2014-05-08 | — | — | US | disclosed |
| US-8637589-B2 | Silicone prepolymer solutions | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2014-01-28 | — | — | US | disclosed |
| EP-2388281-B1 | SILICONE MONOMER | NOF CORP (JP) | 2013-11-06 | — | — | EP | disclosed |
| US-20090171026-A1 | SILICONE PREPOLYMER SOLUTIONS | JOHNSON & JOHNSON VISION CARE, INC. | 2009-07-02 | — | — | US | disclosed |
| US-20090005528-A1 | SOLUBLE SILICONE PREPOLYMERS | JOHNSON & JOHNSON VISION CARE, INC. | 2009-01-01 | — | — | US | disclosed |
| US-20080094570-A1 | Highly Oxygen-Permeable Hydrated Ocular Lens | SEED CO., LTD. (JP) | 2008-04-24 | — | — | US | disclosed |
| US-20080081850-A1 | Such as reaction of butyldimethylsilanol with 3-trichlorosilylpropyl methacrylate to produce 3-[tris(butyldimethylsiloxy)silyl]propyl methacrylate; steric hindrance, purity; copolymers with acrylate endcapped polysiloxane and acrylic monomers; contact and intraocular lenses, artificial cornea | JOHNSON & JOHNSON VISION CARE, INC. | 2008-04-03 | — | — | US | disclosed |
| US-7317117-B2 | Siloxanyl-containing monomers | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2008-01-08 | — | — | US | disclosed |
| US-20080004401-A1 | SILOXANYL MATERIALS FOR MOLDED PLASTICS | JOHNSON & JOHNSON VISION CARE, INC. | 2008-01-03 | — | — | US | disclosed |
| US-20080004383-A1 | ACRYLOYL MATERIALS FOR MOLDED PLASTICS | TORAY INDUSTRIES, INC. (JP) | 2008-01-03 | — | — | US | disclosed |
| EP-1832913-A1 | COMPOSITE CONTACT LENS AND PRODUCTION METHOD FOR LENS MATERIAL | HOYA CORPORATION (JP) | 2007-09-12 | — | — | EP | disclosed |
| EP-1806614-A1 | HIGHLY OXYGEN-PERMEABLE HYDRATED OCULAR LENS | Seed Co., Ltd. (JP) | 2007-07-11 | — | — | EP | disclosed |
| US-20070100018-A1 | Functionalized dyes and use thereof in ophthalmic lens material | OPHTEC B.V. (NL) | 2007-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140128564-A1 | PROCESS FOR PRODUCING HYDROLYSIS-RESISTANT SILICONE COMPOUNDS | LSS, PIGS, STS | TBXAS1 4230/4885CD81 4063/4885PPARG 4290/4885 |
| US-20090005528-A1 | SOLUBLE SILICONE PREPOLYMERS | NOS3, NOS2, PCNA | TBXAS1 617/4885CD81 3667/4885PPARG 2296/4885 |
| US-20080004383-A1 | ACRYLOYL MATERIALS FOR MOLDED PLASTICS | ACR, HAAO, PORCN | TBXAS1 1033/4885CD81 3775/4885PPARG 3268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.